NDC 15631-0210
GRAPHITES
Graphites
GRAPHITES is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Graphite.
| Product ID | 15631-0210_a144c67d-bcd1-5162-e053-2995a90a7e3b |
| NDC | 15631-0210 |
| Product Type | Human Otc Drug |
| Proprietary Name | GRAPHITES |
| Generic Name | Graphites |
| Dosage Form | Pellet |
| Route of Administration | ORAL |
| Marketing Start Date | 2015-10-02 |
| Marketing Category | UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC |
| Labeler Name | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc |
| Substance Name | GRAPHITE |
| Active Ingredient Strength | 1 [hp_X]/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
Packaging
NDC 15631-0210-0
100 PELLET in 1 PACKAGE (15631-0210-0)
| Marketing Start Date | 2018-01-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 15631-0210-1 [15631021001]
GRAPHITES PELLET
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2018-01-01 |
| Inactivation Date | 2020-01-31 |
| Reactivation Date | 2020-03-20 |
NDC 15631-0210-5 [15631021005]
GRAPHITES PELLET
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2018-01-01 |
| Inactivation Date | 2020-01-31 |
| Reactivation Date | 2020-03-20 |
NDC 15631-0210-2 [15631021002]
GRAPHITES PELLET
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2018-01-01 |
| Inactivation Date | 2020-01-31 |
| Reactivation Date | 2020-03-20 |
NDC 15631-0210-0 [15631021000]
GRAPHITES PELLET
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2018-01-01 |
| Inactivation Date | 2020-01-31 |
| Reactivation Date | 2020-03-20 |
NDC 15631-0210-3 [15631021003]
GRAPHITES PELLET
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2018-01-01 |
| Inactivation Date | 2020-01-31 |
| Reactivation Date | 2020-03-20 |
NDC 15631-0210-4 [15631021004]
GRAPHITES PELLET
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2018-01-01 |
| Inactivation Date | 2020-01-31 |
| Reactivation Date | 2020-03-20 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| GRAPHITE | 1 [hp_X]/1 |
OpenFDA Data
| SPL SET ID: | b1267050-2536-47bc-9ed7-89ce49f3d388 |
| Manufacturer | |
| UNII |
NDC Crossover Matching brand name "GRAPHITES" or generic name "Graphites"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0220-2325 | Graphites | GRAPHITE |
| 0220-2360 | Graphites | GRAPHITE |
| 0220-2361 | Graphites | GRAPHITE |
| 0220-2362 | Graphites | GRAPHITE |
| 0220-2363 | Graphites | GRAPHITE |
| 0220-2364 | Graphites | GRAPHITE |
| 0220-2365 | Graphites | GRAPHITE |
| 0220-2366 | Graphites | GRAPHITE |
| 0220-2367 | Graphites | GRAPHITE |
| 0220-2368 | Graphites | GRAPHITE |
| 0220-2369 | Graphites | GRAPHITE |
| 0360-0188 | GRAPHITES | GRAPHITES |
| 0360-0189 | GRAPHITES | GRAPHITES |
| 10191-1795 | GRAPHITES | GRAPHITE |
| 10191-1797 | GRAPHITES | GRAPHITE |
| 15631-0210 | GRAPHITES | GRAPHITES |
| 15631-0594 | GRAPHITES | GRAPHITES |
| 15631-2315 | GRAPHITES | GRAPHITES |
| 37662-0785 | Graphites | Graphites |
| 37662-0786 | Graphites | Graphites |
| 37662-0787 | Graphites | Graphites |
| 37662-0788 | Graphites | Graphites |
| 37662-0789 | Graphites | Graphites |
| 37662-0790 | Graphites | Graphites |
| 37662-0791 | Graphites | Graphites |
| 37662-0792 | Graphites | Graphites |
| 60512-6075 | GRAPHITES | GRAPHITES |
| 62106-5058 | GRAPHITES | Plumbago |
| 68428-412 | Graphites | GRAPHITE |
| 71919-324 | Graphites | GRAPHITE |
| 10191-1794 | GRAPHITE | GRAPHITES |
| 69152-1080 | Graphites 200C | Graphites |
Trademark Results [GRAPHITES]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 GRAPHITES 74578558 not registered Dead/Abandoned |
MORSE SHOE, INC. 1994-09-26 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.